Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oluwatoyin Akinfenwa

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Current Opinion in Allergy and Clinical Immunology|December 28, 2020
Novel vaccines for allergen-specific immunotherapyOluwatoyin Akinfenwa, Azahara Rodríguez-Domínguez, Susanne Vrtala, et al.
Frontiers in Immunology|March 8, 2021
Microarray-Based Allergy Diagnosis: Quo Vadis?Huey-Jy Huang, Raffaela Campana, Oluwatoyin Akinfenwa, et al.
Frontiers in Immunology|November 19, 2021
Preventive Administration of Non-Allergenic Bet v 1 Peptides Reduces Allergic Sensitization to Major Birch Pollen Allergen, Bet v 1Oluwatoyin Akinfenwa, Huey-Jy Huang, Birgit Linhart, et al.
Allergy|September 13, 2023
Natural human Bet v 1-specific IgG antibodies recognize non-conformational epitopes whereas IgE reacts with conformational epitopesGeorgii Brazhnikov, Evgenii Smolnikov, Alla Litovkina, et al.
Allergy|October 19, 2023
Recombinant PreS-fusion protein vaccine for birch pollen and apple allergyMusa Khaitov, Igor Shilovskiy, Rudolf Valenta, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Current Opinion in Allergy and Clinical Immunology|December 28, 2020
Novel vaccines for allergen-specific immunotherapyOluwatoyin Akinfenwa, Azahara Rodríguez-Domínguez, Susanne Vrtala, et al.
Frontiers in Immunology|March 8, 2021
Microarray-Based Allergy Diagnosis: Quo Vadis?Huey-Jy Huang, Raffaela Campana, Oluwatoyin Akinfenwa, et al.
Frontiers in Immunology|November 19, 2021
Preventive Administration of Non-Allergenic Bet v 1 Peptides Reduces Allergic Sensitization to Major Birch Pollen Allergen, Bet v 1Oluwatoyin Akinfenwa, Huey-Jy Huang, Birgit Linhart, et al.
Allergy|September 13, 2023
Natural human Bet v 1-specific IgG antibodies recognize non-conformational epitopes whereas IgE reacts with conformational epitopesGeorgii Brazhnikov, Evgenii Smolnikov, Alla Litovkina, et al.
Allergy|October 19, 2023
Recombinant PreS-fusion protein vaccine for birch pollen and apple allergyMusa Khaitov, Igor Shilovskiy, Rudolf Valenta, et al.
Pageof 1